Argos Therapeutics, Inc. to Present at the 12th Annual Needham Healthcare Conference
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DURHAM, N.C., April 29, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Jeff Abbey, President and Chief Executive Officer, is scheduled to present at Needham & Company's 12th Annual Healthcare Conference at the Westin Grand Central Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.
DURHAM, N.C., April 29, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Jeff Abbey, President and Chief Executive Officer, is scheduled to present at Needham & Company's 12th Annual Healthcare Conference at the Westin Grand Central Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.